Episode 1095: The Science Behind the Struggle | New Spirit Recovery

Episode 1095: The Science Behind the Struggle | New Spirit Recovery

Addiction isn't a character flaw or moral failing—it's a complex, chronic brain disease affecting 48.7 million Americans. Yet only 13% receive the specialized care they need. In this episode of The Behavioral Health Answers Podcast, we explore Types of Addiction: Causes, Signs, and Treatment through a scientific lens that replaces judgment with evidence-based understanding. From the neurobiological changes that rewire reward pathways to the genetic and environmental factors that create vulnerability, we break down what's really happening in the brain.

In this episode, we discuss:

• How addiction rewires the brain's dopamine system, shifting from "liking" to compulsive "wanting"
• The three-stage cycle of binge/intoxication, withdrawal, and preoccupation that traps users
• Warning signs including tolerance, hypofrontality, and life-threatening overdose emergencies
• Genetic vulnerability factors and environmental triggers that compound addiction risk
• Evidence-based treatment pathways from medical detox through long-term recovery support

This episode emphasizes an important takeaway: addiction is a highly treatable medical condition driven by neurobiology, not willpower. With structured care including FDA-approved medications, cognitive behavioral therapy, and trauma treatment, the brain can physically heal and people can reclaim their lives. Recovery is not only possible—it's scientifically proven.

This podcast is for educational and informational purposes only and is not a substitute for professional medical, mental health, or legal advice.

Transcript

SPEAKER_01 0:00

Today, we're gonna fundamentally shift our perspective on a topic that is just so profoundly misunderstood. You know, for decades, society has sort of looked at addiction as a character flaw, right? Like it's a lack of willpower or some kind of moral failing. But today, we're throwing that idea out and looking at the measurable scientific reality. We're gonna explore addiction for what it truly is: a complex, chronic brain disease. By the time we wrap up, you're gonna have a really clear scientific framework for understanding exactly how addiction works, how to spot it, and most importantly, how we can actually treat it. Okay, let's dive into this roadmap. We'll be defining the disease, looking at how it physically rewires the brain, comparing different substances and behaviors, recognizing those warning signs, unpacking the genetics of why some people are more vulnerable, and finally, mapping out our real paths to recovery. Now, I want to start us off with a number that is honestly just staggering. 48.7 million. According to the 2023 National Survey on Drug Use and Health, that is the number of Americans age 12 or older who met the actual clinical criteria for a substance use disorder in the past year. 48.7 million people. But here is the truly heartbreaking part of that statistic. Fewer than 13% of those individuals actually received any form of specialty addiction treatment. Think about that massive gap between the need for care and the delivery of care. That's exactly why understanding the hard science of this disease is absolutely crucial. Because to close that gap, we all need to be speaking the same language. All right, jumping right into section one, defining the disease. So, according to the American Society of Addiction Medicine and the DSM 5, addiction, which is clinically referred to as a substance use disorder, is simply not a choice. It is a chronic brain disease. And I really want you to notice the key phrases here: compulsive seeking, continued use despite harmful consequences, and lasting neurobiological changes. The initial choice to use a substance, sure, that might be voluntary. But once this disease takes hold, the brain's reward and motivation circuits are fundamentally altered. It's a completely different ballgame. And clinicians don't just, you know, guess if someone has this disease, they use a highly specific framework. The DSM 5 evaluates severity using 11 criteria spread across four diagnostic domains. First up is impaired control, so that's like wanting to cut down but failing. Then there's social impairment, where the use starts disrupting work, school, or relationships. Next is risky use, meaning using in physically hazardous situations. And finally, pharmacological indicators, which basically means building a physical tolerance to a substance or experiencing withdrawal when you stop. The more criteria a person meets, the more severe the diagnosis. So what is actually going on inside the head of someone who meets those criteria? That brings us to section two, rewiring the brain. Now, what's really interesting about this slide is the profound contrast between liking a substance and wanting it. When a person first uses an addictive substance, it literally floods the brain's nucleus accumbents with dopamine. We're talking two to ten times the amount you get from natural rewards. But over time, the brain tries to protect itself from this massive flood by shutting down its own dopamine receptors, specifically the D2 receptors. This means the person actually stops liking the substance. The pleasure totally diminishes, dropping them into a state of anhedonia, which is the inability to feel pleasure at all. However, through a process called incentive sensitization, everyday environmental cues trigger a compulsive biological necessity or a wanting for the drug. They aren't using to get high anymore. They're using because their brain is literally telling them they need it to survive. And this biological trap basically operates in a three-stage cycle. In step one, the binge or intoxication stage, the motivation is positive reinforcement, you know, chasing that dopamine reward. But as the brain adapts, the user drops into step two, withdrawal and negative affect. This is where the brain's stress systems activate, creating what researchers call hypercotophia, which is just an intense physical and emotional misery. The motivation shifts entirely to negative reinforcement. They're just using to escape the pain of withdrawal. Then comes step three, preoccupation and anticipation, where compromised function in the prefrontal cortex makes the person obsess over their next dose, completely bypassing any conscious control. And this cycle, it isn't unique to just one type of drug. Let's look at that in section three, substances and behaviors. Whether we're talking about chemical substances or certain behaviors, they actually share the exact same dopaminergic signature in the brain. But the withdrawal risks vary drastically depending on the substance. Take alcohol and benzodiazepines, for example. Withdrawal from these depressants can actually cause life-threatening seizures and delirium tremens. That's why medical detox for those is absolutely mandatory. Opioids carry a high risk of what's known as a norogenergic storm and severe physical dependence. Stimulants, like cocaine or meth, on the other hand, don't typically cause deadly physical withdrawal, but they do produce a high risk of prolonged crushing depression and anhedonia. And then there's gambling. No chemicals involved, but the DSM-5 formally recognizes gambling as an addictive disorder because it hijacks the exact same neural pathways as drugs, causing withdrawal equivalent restlessness. So, knowing that the brain is physically altered by these things, what does that actually look like on the outside? Let's talk about that in section four, recognizing the warning signs. When those reward circuits are pathologically altered, we see really visible behavioral red flags, like tolerance development and withdrawal. But we also see a total loss of control, the abandoning of valued activities, and persistent craving despite obvious harm. And this brilliantly illustrates a concept called hypofrontality. Basically, the prefrontal cortex, which is the part of the brain responsible for impulse control and decision making, actually shows reduced metabolic activity. The brain's rational breaks have essentially been cut. And that is exactly why someone will continue a highly destructive habit, even when it's costing them their job, their health, or their family. Now, this is absolutely crucial. I need you to focus for a second, because recognizing this next sign can literally save a life. If someone exhibits slow, shallow, or stopped breathing, this is respiratory depression, and it's very often caused by an opioid or fentanyl overdose. This is a severe medical emergency. You must administer naloxone, which you probably know is narcan, immediately, and then call 911 right away. Naloxone works by rapidly knocking the opioids off the brain's receptors, which reverses the respiratory depression within minutes. But remember, always call 911 after administering it, because that overdose can come right back once the narcan wears off. Moving on to section five, why some are vulnerable? So you might be wondering if the mesolimbic dopamine pathway works relatively the same in all of us, why are only some people vulnerable to developing this disease when they're exposed to a substance? Well, according to the National Institute on Drug Abuse, a massive 40 to 60% of an individual's vulnerability to addiction is purely genetic. This is not about willpower, guys. This is straight biology. Researchers have found that certain genetic variants, specifically those D2 receptor gene polymorphisms, directly influence just how sensitive your reward pathways are. If you have a first degree relative with a substance use disorder, your neurobiological vulnerability is substantially higher before you even take your first sip or pop your first pill. But genetics, you know, they're just one piece of the puzzle. The environment is what pulls the trigger. Environmental risks compound that inherited genetic vulnerability. Things like early childhood trauma, which is often measured as adverse childhood experiences or ACEs, physically activates the brain's extended amygdala stress circuits super early in life. Add to that co-occurring mental health conditions like PTSD or depression, chronic stress, or, this is a big one, beginning substance use before the age of 15. In fact, using before age 15 increases the lifetime probability of an addiction two to four times compared to waiting until age 21. When these environmental stressors combine with those genetic predispositions, the risk of the brain's reward system becoming completely hijacked just skyrockets. Finally, let's look at the solution in section six, the path to recovery. Because addiction is a chronic biological disease, the good news is that it responds incredibly well to medical treatment. But treating it requires a structured continuum of care, not just some quick fix. Let's move to and see how this builds based on guidelines from the American Society of Addiction Medicine. The safest progression starts with medical detox. This provides 24-hour medical supervision to safely manage withdrawal and physically stabilize the patient. Once they're stable, they step into residential treatment for intensive, daily therapeutic programming entirely away from their normal environmental triggers. Then, they step down to partial hospitalization or intensive outpatient programs, slowly reintegrating back into daily life while still maintaining heavy clinical support. And finally, ongoing outpatient and alumni care, which provides the long-term maintenance you absolutely need for a chronic relapsing condition. And woven throughout that entire timeline is actual evidence-based care. We're not just talking about sitting in a group circle, we are talking about targeted FDA-approved medical interventions. For example, medications for opioid use disorder, like biprenorphin, physically, chemically stabilize the brain, reduce those cravings, and prevent withdrawal without producing a euphoric high. This allows the patient to actually engage in things like cognitive behavioral therapy to start rebuilding their compromised prefrontal cortex, it allows for dual diagnosis treatment to address the underlying depression or anxiety, and trauma therapies like EMDR to calm down those hyperactive stress circuits in the amygdala. Over time, these treatments physically help resensitize the brain. So as we wrap up this explainer today, I really want to leave you with a question to chew on. If we truly understand addiction as a highly treatable, complex brain disease, one that's driven by genetics, trauma, and neurobiology, rather than some kind of character flaw, how does that fundamentally change how we support the people struggling right in our own communities? The science is clear, the treatments exist, and the path to recovery is very, very real. It's up to us to replace judgment with evidence-based compassion.

SPEAKER_00 10:00

The information shared on this podcast is for educational and informational purposes only, and is not intended as medical, psychological, or professional advice. The content discussed does not constitute diagnosis, treatment, or medical recommendations of any kind. Always seek the advice of a qualified physician, licensed mental health professional, or other qualified healthcare provider with any questions you may have regarding a medical or mental health condition, addiction treatment, or behavioral health care. Never disregard professional medical advice or delay seeking treatment because of something you have heard on this podcast. Individual experiences with addiction and mental health are unique. And treatment options vary based on personal circumstances. If you or someone you know is experiencing a medical or mental health emergency, including thoughts of self harm or overdose, please contact emergency services immediately or reach out to a local crisis hotline.